Veritas scheme sets 75 percent vote for Bodycote stock

Published on 10/13/2026 at 05:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The timetable targets completion in the first quarter of 2027. The vote sets October 21, 2026 as the next date for Bodycote stock.

Key points in brief

Bodycote published the Veritas scheme document on September 28, 2026.
The court meeting requires 75.00 percent approval by value of voted scheme shares.
First-half 2026 revenue rose 3.00 percent to GBP 381.2 million and net income reached GBP 31.0 million.
Shareholder meetings are scheduled for October 21, 2026, with completion expected in the first quarter of 2027.

Bunte Pop-Art-Comicszene eines Arbeiters an einem glühenden Industrieofen mit Metallteilen — Pop-Art-Comic-Szene eines Arbeiters an einem Industrieofen mit Metallteilen, farbenfroh gestaltet für Bodycote plc, ISIN GB00B3FLWH99, Illustration mit AI erstellt.

Bodycote plc (ISIN GB00B3FLWH99) published its Veritas scheme document on September 28, 2026, setting a 75.00 percent approval threshold by value for the court meeting, according to Financial Times. Bodycote stock is therefore tied to two shareholder meetings on October 21, 2026, subject to court sanction and other conditions.

Three dates shape the scheme

The chronology starts on September 28, 2026, when Bodycote published the scheme document and confirmed the 75.00 percent value threshold. On October 19, 2026, proxy deadlines arrive at 10:00 a.m. for the court meeting and 10:15 a.m. for the general meeting. On October 21, 2026, the court meeting is scheduled for 10:00 a.m., followed by the general meeting at 10:15 a.m., according to Financial Times.

What does the vote mean?

The 75.00 percent threshold applies to the value of scheme shares voted at the court meeting, while a separate special resolution is required at the general meeting. The transaction is expected to become effective in the first quarter of 2027, but the timetable still includes court approval and other conditions, according to Financial Times.

Results add operating context

Bodycote's first-half 2026 revenue increased 3.00 percent to GBP 381.2 million from GBP 369.0 million in the first half of 2025. Net income rose from GBP 27.7 million to GBP 31.0 million, while net margin increased from 7.50 percent to 8.10 percent, according to Simply Wall St. The comparison gives investors an operating benchmark while the takeover process moves toward its October vote.

Next dates for shareholders

The next two dated milestones are October 19, 2026, for proxy submissions, and October 21, 2026, for the court and general meetings, according to Financial Times. The further course of trading is shown by the continuously updated real-time quote of Bodycote stock.